BioRestorative Therapies, Inc.
BRTX Nasdaq
SEC CIK 1505497
Follow BioRestorative Therapies
Weekly email: filings, results
Revenue, last quarter
$23.2K
−7.3% vs same quarter last year
Net income
−$2.2M
+59.7% vs same quarter last year
EPS, diluted
−$0.12
+81.3% vs same quarter last year
Operating cash flow
−$3.8M
−37% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $359.7K | −$14.2M |
| FY24 | $401K | −$9M |
| FY23 | $145.8K | −$10.4M |
| FY22 | $119.8K | −$13.2M |
| FY21 | $46K | −$44.3M |
| FY20 | $77K | −$11.3M |
| FY19 | $130K | −$14.6M |
| FY18 | $111K | −$12.5M |
| FY17 | $81K | −$9.4M |
| FY16 | $36.4K | −$8.6M |
| FY15 | $628.9K | −$7.9M |
| FY14 | $416K | −$5.6M |
| FY13 | $1.7K | −$5.8M |
| FY12 | $15.6K | −$6.5M |
| FY11 | $0 | −$4.1M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 93.4% | −4350.1% | −3959.4% |
| FY24 | 93% | −2881.6% | −2239.2% |
| FY23 | 100% | −10439.5% | −7145.2% |
| FY22 | - | −15838.1% | −11037% |
| FY21 | - | −57191% | −96311.5% |
| FY20 | - | −3574.1% | −14639.9% |
| FY19 | - | −6486.2% | −11267.6% |
| FY18 | - | −6889.8% | −11277.3% |
| FY17 | 100% | −10338.6% | −11660.1% |
| FY16 | 99.7% | −21414% | −23755.4% |
| FY15 | 58.4% | −1140.1% | −1259.9% |
| FY14 | 48.6% | −1183.3% | −1343.2% |
| FY13 | 87.6% | −282873.2% | −342333% |
| FY12 | 91.6% | −35746.1% | −41931.6% |
| FY11 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$10.9M |
| FY24 | −$8.3M |
| FY23 | −$6.6M |
| FY22 | −$6.2M |
| FY21 | −$3.4M |
| FY20 | - |
| FY19 | −$7M |
| FY18 | −$5.1M |
| FY17 | −$3.9M |
| FY16 | −$5.2M |
| FY15 | −$3.5M |
| FY14 | −$3.4M |
| FY13 | −$2.7M |
| FY12 | −$3.2M |
| FY11 | −$2.8M |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $0 |
| FY24 | - |
| FY23 | - |
| FY22 | - |
| FY21 | - |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
| FY14 | - |
| FY13 | $0 |
| FY12 | $0 |
| FY11 | $4K |
- BioRestorative Therapies
- Healthcare median
Show the numbers
| Year | BioRestorative Therapies | Healthcare median |
|---|---|---|
| FY25 | −3959.4% | −30.6% |
| FY24 | −2239.2% | −47% |
| FY23 | −7145.2% | −58% |
| FY22 | −11037% | −80.4% |
| FY21 | −96311.5% | −71.9% |
| FY20 | −14639.9% | −62.2% |
| FY19 | −11267.6% | −46.3% |
| FY18 | −11277.3% | −49.6% |
| FY17 | −11660.1% | −45.9% |
| FY16 | −23755.4% | −36% |
| FY15 | −1259.9% | −38.4% |
| FY14 | −1343.2% | −35.5% |
| FY13 | −342333% | −37.1% |
| FY12 | −41931.6% | −29.1% |
| FY11 | - | −27.9% |